Chemokines in inflammatory bowel diseases.
1Medical Clinic 1, University of Erlangen-Nuremberg, Erlangen, Germany. raja.atreya@uk-erlangen.de
Digestive Diseases (Basel, Switzerland)
|October 8, 2010
Summary
Chemokines drive inflammatory bowel diseases (IBD) by activating mucosal cells. Targeting these chemokines or their receptors may offer new therapeutic strategies for IBD.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Inflammatory bowel diseases (IBD) are characterized by uncontrolled mucosal effector cell activation.
- This sustained activation leads to the release of pro-inflammatory mediators, amplifying the disease process.
- Chemokines and their receptors play a critical role in initiating and perpetuating intestinal inflammation in IBD.
Purpose of the Study:
- To elucidate the role of chemokines in the pathogenesis of inflammatory bowel diseases (IBD).
- To highlight the potential of targeting chemokine pathways for novel IBD therapeutics.
Main Methods:
- Review of existing literature on chemokine involvement in IBD pathogenesis.
- Analysis of chemokine expression patterns in IBD lesions.
- Discussion of the functional roles of chemokines in leukocyte recruitment and inflammatory mediator release.
Main Results:
- Chemokine expression is significantly upregulated in the intestine during IBD and correlates with disease activity.
- Chemokines orchestrate leukocyte adhesion, migration, and the release of inflammatory mediators.
- These molecules also influence tumorigenesis, matrix metalloproteinase release, and tissue fibrosis.
Conclusions:
- Chemokines are central players in the immunopathogenesis of IBD.
- Understanding the specific roles of chemokines and their receptors in intestinal inflammation is crucial.
- Development of selective chemokine or chemokine receptor inhibitors presents a promising therapeutic avenue for IBD.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...